The site of the Media Sphera Publishers contains materials intended solely for healthcare professionals.
By closing this message, you confirm that you are a certified medical professional or a student of a medical educational institution.

Login
EN
+7 (495) 482-4118
+7 (495) 482-0604
+8 800 101-59-87
  • (toll-free number for subscriptions)
    Mon-Fri from 10 a.m. to 6 p.m.

  • © 1998-2024
+7 (495) 482-43-29
EN
All journals
Journal
Year
Year
Search result: 0

Shchuko A.G.

GOU VPO "Irkutskiĭ gosudarstvennyĭ meditsinskiĭ universitet"

Zlobin I.V.

Irkutskiĭ filial FGBU "MNTK "Mikrokhirurgiia glaza" im. akad. S.N. Fedorova

Iur'eva T.N.

Irkutskiĭ filial FGBU "MNTK "Mikrokhirurgiia glaza" im. akad. S.N. Fedorova

Ostanin A.A.

Research Institute of Fundamental and Clinical Immunology, 14 Yadrintsevskaya St., Novosibirsk, Russian Federation, 630099

Chernykh E.R.

Research Institute of Fundamental and Clinical Immunology, 14 Yadrintsevskaya St., Novosibirsk, Russian Federation, 630099

Intraocular cytokines imbalance in retinal vein occlusion and its impact on the efficacy of anti-angiogenic therapy

Authors:

Shchuko A.G., Zlobin I.V., Iur'eva T.N., Ostanin A.A., Chernykh E.R.

More about the authors

Journal: Russian Annals of Ophthalmology. 2015;131(2): 50‑58

DOI: 10.17116/oftalma2015131250-58

Views: 559

Downloaded: 19

Download PDF (RU)
Contact the author
Table of contents

To cite this article:

Shchuko AG, Zlobin IV, Iur'eva TN, Ostanin AA, Chernykh ER. Intraocular cytokines imbalance in retinal vein occlusion and its impact on the efficacy of anti-angiogenic therapy. Russian Annals of Ophthalmology. 2015;131(2):50‑58. (In Russ.)
https://doi.org/10.17116/oftalma2015131250-58

Подписка 2025 (Russian Annals of Ophthalmology)
 
МСФ на ЯМ
Close metadata

Aim — to study the concentrations of intraocular cytokines in patients with retinal vein occlusion (RVO) before and after intravitreal ranibizumab injection and to compare the results with clinical activity of the disease and treatment efficacy. Material and methods. A comprehensive ophthalmological examination of 44 patients with RVO and macular edema was performed. Intraocular fluid was first collected before the intravitreal injection. Cytokines concentrations were measured using Bio-Plex Pro Human Cytokine 27-plex Panel (Bio-Rad Laboratories, USA) for flow cytometry. The test was repeated 1 month after the injection. Results. A total of 11 cytokines were reliably detected. After ranibizumab injections certain angiogenic (VEGF) and proinflammatory (IL-6, IL-8, IL-13, IL-15, MCP-1) factors appeared to be significantly suppressed. Clinical efficacy of the therapy correlated with the degree of cytokines suppression, which in turn depended on the severity of ocular involvement at baseline. Conclusions. Retinal vein occlusion pathogenesis involves a cascade of immune and inflammatory processes, including activation of not only VEGF but also quite a few inflammatory and chemotactic factors, whose activity depends on the extent of ischemic damage in the retina.

Keywords:

cytokines in intraocular fluid
retinal ischemia
anti-VEGF therapy efficacy

Authors:

Shchuko A.G.

GOU VPO "Irkutskiĭ gosudarstvennyĭ meditsinskiĭ universitet"

Zlobin I.V.

Irkutskiĭ filial FGBU "MNTK "Mikrokhirurgiia glaza" im. akad. S.N. Fedorova

Iur'eva T.N.

Irkutskiĭ filial FGBU "MNTK "Mikrokhirurgiia glaza" im. akad. S.N. Fedorova

Ostanin A.A.

Research Institute of Fundamental and Clinical Immunology, 14 Yadrintsevskaya St., Novosibirsk, Russian Federation, 630099

Chernykh E.R.

Research Institute of Fundamental and Clinical Immunology, 14 Yadrintsevskaya St., Novosibirsk, Russian Federation, 630099

List of references:

  1. Funk M, Kriechbaum K, Prager F, Benesch T, Georgopoulos M, Zlabinger GJ, Schmidt-Erfurth U.Intraocular concentrations of growth factors and cytokines in retinal vein occlusion and the effect of therapy with bevacizumab. Invest Ophthalmol Vis Sci. 2009;50:1025-1032. doi:10.1167/iovs.08-2510
  2. Noma H, Funatsu H, Yamasaki M, Tsukamoto H, Mimura T, Sone T, Jian K, Sakamoto I, Nakano K, Yamashita H, Minamoto A, Mishima HK. Pathogenesis of macular edema with branch retinal vein occlusion and intraocular levels of vascular endothelial growth factor and interleukin-6. Am J Ophthalmol. 2005;140:256-261. doi:10.1016/j.ajo.2005.03.003
  3. Simbirtsev A. Cytokines - a new system of regulation of defense reactions. Tsitokiny i vospalenie. 2002;1 (1):9-16. (In Russ.)
  4. Oppenheim J, Feldman M. Cytokine Reference. London: Academic Press; 2000:2000-2015
  5. Simbirtsev A. Cytokines: classification and biological functions. Tsitokiny i vospalenie. 2004;3(2):16-23. (In Russ.)
  6. Berezhnaya N. Cytokine regulation in pathology: rapid development and the inevitable questions. Tsitokiny i vospalenie. 2007;6(2):26-34. (In Russ.)
  7. Simbirtsev A. Achievements and prospects for the use of recombinant cytokines in clinical practice. Meditsinskii akademicheskii zhurnal. 2013;13(1):7-22. (In Russ.)
  8. Skurkovich S, Skurkovich B, Kelly J. Anticytokine therapy - a new approach to the treatment of autoimmune diseases and disorders of cytokine. Voprosy gematologii, onkologii i immunologii v pediatrii. 2003;4:71-81. (In Russ.)
  9. Lazebnik L, Tsaregorodtseva T, Serova T. eds. Cytokines and Cytokine therapy in diseases of the digestive system. Ter ?rkh. 2004;4:69–72. (In Russ.)
  10. Dzhambinova N, Guseva M, Sidorenko E, Gankovskaya L, Koval'chuk L, Fedorov A, Gorbunova N, Kuznetsova Yu. Cytokine therapy in the regulation of reparative processes of the cornea (experimentally-clinical research). Vestnik oftal'mologii. 2009;(6):18-21. (In Russ.)
  11. Gavrilova N, Gadzhieva N, Fedorov A, Lukina G, Shirokov V. Anticytokine (anti-TNF-a) therapy in ophthalmology. Oftal'mokhirurgiya. 2013;2:78-84. (In Russ.)
  12. Wakefield D, Lloyd A. The role of cytokines in the pathogenesis of inflammatory eye disease. Cytokine. 1992;4(1):1-5. doi:10.1016/1043-4666(92)90028-P
  13. Franks WA, Limb GA, Stanford MR, Ogilvie J, Wolstencroft RA, Chignell AH, Dumonde DC. Cytokines in human intraocular inflammation. Current Eye Research, Informa Healthcare. 1992;11(1):187-191. doi:10.3109/02713689208999531
  14. Aiello L, Avery R, Arrigg P, Keyt B, Jampel H, Shah ST, Pasquale LR, Thieme H, Iwamoto MA, Park JE et al. Vascular endothelial growth factor in ocular fluid of patients with diabetic retinopathy and other retinal disorders. N Engl J Med. 1994;331:1480-1487. doi:10.1056/NEJM199412013312203
  15. Funatsu H, Yamashita H, Ikeda T, Mimura T, Eguchi S, Hori S. Vitreous levels of interleukin-6 and vascular endothelial growth factor are related to diabetic macular edema. Ophthalmology. 2003;110:1690-1696. doi:10.1016/S0161-6420(03)00568-2
  16. Funatsu H, Yamashita H, Noma H, Mimura T, Nakamura S, Sakata K, Hori S. Aqueous humor levels of cytokines are related to vitreous levels and progression of diabetic retinopathy in diabetic patients. Graefes Arch Clin Exp Ophthalmol. 2005;243:3-8. doi:10.1007/s00417-004-0950-7
  17. Jonas J, Kreissig I, Degenring R. Intravitreal triamcinolone acetonide as treatment of macular edema in central retinal vein occlusion. Graefes Arch Clin Exp Ophthalmol. 2002;240:782-783. doi:10.1097/00006982-200306000-00052
  18. Park C, Jaffe G, Fekrat S. Intravitreal triamcinolone acetonide in eyes with cystoid macular edema associated with central retinal vein occlusion. Am J Ophthalmol. 2003;136(3):419-425. doi:10.1016/S0002-9394(03)00228-9
  19. Iturralde D, Spaide R, Meyerle C, Klancnik J, Yannuzzi L, Fisher Y, Sorenson J, Slakter J, Freund K, Cooney M, Fine H. Intravitreal bevacizumab (Avastin) treatment of macular edema in central retinal vein occlusion:a short-term study. Retina. 2006;26(3):279-284. doi:10.1097/00006982-200603000-00005
  20. Noma H, Funatsu H, Yamasaki M, Tsukamoto H, Mimura T, Sone T, Hirayama T, Tamura H, Yamashita H, Minamoto A, Mishima HK. Aqueous humour levels of cytokines are correlated to vitreous levels and severity of macular edema in branch retinal vein occlusion. Eye. 2008;22:42-48. doi:10.1038/sj.eye.6702498
  21. Boyd SR, Zachary I, Chakravarthy U, Allen GJ, Wisdom GB, Cree IA, Martin JF, Hykin PG. Correlation of increased vascular endothelial growth factor with neovascularization and permeability in ischemic central vein occlusion. Arch Ophthalmol. 2002;120:1644-1650. doi:10.1001/archopht.120.12.1644
  22. Karia N. Retinal vein occlusion: pathophysiology and treatment options. Clin Ophthalmol. 2010;4:809-816. doi:10.2147/opth.s7631
  23. Cohen T, Nahari D, Cerem L, Neufeld G, Levi B. Interleukin 6 induces the expression of vascular endothelial growth factor. J Biol Chem. 1996;271(2):736-741. doi:10.1074/jbc.271.2.736
  24. Ostanin A, Leplina O, Shevela E, Chernykh E, Konenkov V. Assessment of cytokine profile in patients with severe sepsis by flow fluorometry (Bio-Plex analysis). Tsitokiny i vospalenie. 2004;3(1):20-27. (In Russ.)
  25. Shchuko A, Zlobin I, Yur'eva T, Mikhalevich I. Comprehensive assessment of risk factors for retinal vein occlusion and derivation of classification criteria for retinal ischemia. Vestnik oftal'mologii. 2014;5:54-59. (In Russ.)
  26. Shchuko A, Malyshev V. Opticheskaya kogerentnaya tomografiya v diagnostike glaznykh boleznei. Moscow: GEOTAR-Media; 2010. (In Russ.)
  27. Shchuko A, Zhukova S, Yur'eva T. Ul'trazvukovaya diagnostika v oftal'mologii. Moscow: Oftal'mologiya; 2013. (In Russ.)

Close metadata

Contact the author
Email
Message
The publishing house "Media Sphere" does not provide treatment services, does not give recommendations on contacting medical institutions and specific specialists, on the prescription of medicines and dietary supplements.

Email Confirmation

An email was sent to test@gmail.com with a confirmation link. Follow the link from the letter to complete the registration on the site.

Email Confirmation

Contact us
If you have any questions, complaints or suggestions, please use this feedback form.
Email
Message
The publishing house "Media Sphere" does not provide treatment services, does not give recommendations on contacting medical institutions and specific specialists, on the prescription of medicines and dietary supplements.
Submit Application

You can become an author of one of our magazines, send a request and we will consider it in during the day.

Name
Phone
E-mail
Message
Login
Registration
E-mail
Password
Forgot Password?

Log in to the site using your account in one of the services

Password recovery
E-mail
Login
Register


We use cооkies to improve the performance of the site. By staying on our site, you agree to the terms of use of cооkies. To view our Privacy and Cookie Policy, please. click here.